where does BABA close 2014 - 110?
I would guess between 100 and 110.
No rush to get higher than 120 until 03/2015 to shake out;
Could go lower than 100, too
Can I ask when you bought ABBV and GILD.
What is your average cost of each;
Both experienced hiccups along the way, but never stay down for long.
DIV stocks don't appreciate as fast as non-div (such as GILD);
but the div limits downside.
Assume 2015 as good as 2014, ABBV should trade in the 80s.
No guarantees (glad Shire no negative factor)
In early 2014 Barron's presented a comment FLR's cash flow is good;
if stock gets depressed, can go private;
only issue is the low-ball offer from its 52-week lows.
If true, then don't expect 80s range.
The slow recovery to oil, in a couple of years can result in share price higher;
Notice several other engineering companies in 2014 got taken out; URS is one of them at lows.
Appears IMMR forming a base to move higher;
or could be a fake-out - always starts day higher but gives back most of gains at closing;
just wondering since you held IMMR at higher prices, what's your break-even price?
This small-cap has underperformed in 2014;
tax selloff might be over;
CNBC has Cramer for the ratings as many tune in to watch his antics;
just an average performer - does not stand out from the crowd.
GILD will have dips, but recover; no one drug will make/break this company;
GILD back over 100 in 2015; selloff about over and in all health-care related stocks, if today is indication.
Both good to own, instead of picking one over the other.
ESRX to go with ABBV was good opportunity to add/buy GILD on the selloff for individual buyers.
Institutions dump, will buy back later.
Always the case with quality stocks taking temporary hit.
Prediction: ABBV over 70 in 2015; with steady move to 80-90 range.
Done good for 2014 coming to a close with Shire merger no-go.
Can I ask if 335 is on sale today, then your sell price target.
Could go lower another $30; buy more?
Biotech and health care going through a year-end pullback...had to happen eventually
health care stocks have had a good run in 2014; it was an excuse for profit taking, not just Hep C;
GILD going through what the S&P500 correction gone through in mid September to October period; December 5-16 before the bounce.
health care stock got way overbought, now has to get into oversold territory;
best advice is dollar-cost average on the way down with a limit, say down to 80.
healthy correction; I'll stick to VHT
All health care stocks taking a beating with pullback - is it profit taking at year-end?
AMGN, GILD, ABBV, BIIB, VHT, ACT...etc.
ABBV not as much losses as the others.
The Hep C was just the excuse for all other health-care stocks pullback IMO.
No place to hide but invest in the S&P500
NP won't get to $70 by 12/31/14.
More likely only to be around its 52-week high of low 60s.
Just want to avoid any gaps down; has had a good return for 2014.
My other paper-related holding GLT hasn't done as good!
Are you short BABA expecting to cover at 90?
How did you arrive at 90 - and not some other number like 100.
Remember, this is year-end tax selling to lock in profits for those buying at IPO price.
There is no negative news to make BABA spike down over 10% any given day.
If IMMR can stay above 9, could have legs to reach 10;
should see over 10 some time in 2015; if not, will be very surprised.
Need agitator to buy a 10% position to put pressure on management to increase shareholders valve (should be a $20 stock but has under performed with latest tech device)
"GILD is the same company right now that it was when it was trading at 116" - only difference is it is at a lower price from 116 down to 88-89.
Time to buy more shares as price goes lower?
You going to get back in when GILD goes to 70 range?
Why not hang in there and buy more shares at lower price, when a bounce will occur!
Need guts to bottom fish; no dead-cat bounce today as more profit taking.
Could go 88-89 range to buy on the dips.
if buy @ 92-95 range, you sell on the bounce?
Buy more if GILD goes lower?
Tomorrow probably a $2-$5 bounce for the swing traders
what was the remedy to treat?
Or all died from liver disease?
It's all about how much to charge the patient the big issue!
Reduce the price to charge or stand your ground for GILD?